Aspen, Strides Arcolab Ink Agreement

South African drugmaker Aspen signed an agreement with India’s Strides Arcolab.

Under the agreement, Aspen will become a partner in Strides’ Latin American operations. Strides operates in Brazil as Cellofarm and in Mexico as Solara.

The companies will enter a 50-50 joint venture to develop and manufacture oncology products through Strides’ Powercliff and Onco therapies.

Strides also will acquire a 51 percent interest in Co Pharma, Aspen’s UK-based generics subsidiary, and 80 percent of Formula Naturelle, Aspen’s nutraceutical subsidiary.